Murray B. Urowitz

46.9k total citations · 4 hit papers
360 papers, 19.6k citations indexed

About

Murray B. Urowitz is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Murray B. Urowitz has authored 360 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 309 papers in Rheumatology, 149 papers in Immunology and 76 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Murray B. Urowitz's work include Systemic Lupus Erythematosus Research (293 papers), Atherosclerosis and Cardiovascular Diseases (101 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Murray B. Urowitz is often cited by papers focused on Systemic Lupus Erythematosus Research (293 papers), Atherosclerosis and Cardiovascular Diseases (101 papers) and Monoclonal and Polyclonal Antibodies Research (74 papers). Murray B. Urowitz collaborates with scholars based in Canada, United States and United Kingdom. Murray B. Urowitz's co-authors include Dafna D. Gladman, Dominique Ibañez, Zahi Touma, Jiandong Su, Ian N Bruce, Mahmoud Abu‐Shakra, Paul R. Fortin, H A Smythe, Konstantinos Tselios and Duncan A. Gordon and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Murray B. Urowitz

351 papers receiving 19.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX

2007 2.3k citations Dafna D. Gladman, Dominique Ibañez et al. profile →
Systemic lupus erythematosus

2016 849 citations Zahi Touma, Murray B. Urowitz et al. profile →
The bimodal mortality pattern of systemic lupus erythematosus

1976 756 citations Murray B. Urowitz, Duncan A. Gordon et al. profile →
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index in patients with Systemic Lupus Erythematosus

1997 587 citations Dafna D. Gladman, Murray B. Urowitz et al. Arthritis & Rheumatism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Murray B. Urowitz Canada	73	16.3k	9.9k	3.5k	3.2k	1.5k	360	19.6k
Caroline Gordon United Kingdom	67	12.5k 0.8×	8.0k 0.8×	3.4k 1.0×	2.5k 0.8×	1.3k 0.8×	305	17.3k
Anǵela Tincani Italy	71	15.0k 0.9×	7.2k 0.7×	2.9k 0.8×	1.9k 0.6×	2.6k 1.7×	451	21.3k
Naomi F. Rothfield United States	48	12.7k 0.8×	7.8k 0.8×	4.1k 1.2×	4.6k 1.4×	1.6k 1.0×	125	19.8k
Graham R.V. Hughes United Kingdom	68	13.6k 0.8×	4.4k 0.4×	2.5k 0.7×	2.5k 0.8×	1.7k 1.1×	263	18.2k
Michelle Petri United States	99	25.7k 1.6×	16.7k 1.7×	7.3k 2.1×	3.8k 1.2×	3.2k 2.0×	534	33.5k
Munther A. Khamashta United Kingdom	84	22.6k 1.4×	10.1k 1.0×	4.1k 1.2×	3.1k 1.0×	3.5k 2.3×	411	31.3k
Jill P. Buyon United States	74	9.8k 0.6×	7.1k 0.7×	2.9k 0.8×	1.0k 0.3×	1.5k 1.0×	320	17.1k
Zahir Amoura France	75	7.3k 0.5×	6.3k 0.6×	1.3k 0.4×	1.8k 0.6×	1.1k 0.7×	424	17.6k
Miguel Á. González‐Gay Spain	81	13.5k 0.8×	6.3k 0.6×	1.1k 0.3×	2.3k 0.7×	2.0k 1.3×	799	25.0k
Ian N Bruce United Kingdom	59	8.4k 0.5×	6.1k 0.6×	1.9k 0.5×	1.5k 0.5×	537 0.3×	310	12.1k

Countries citing papers authored by Murray B. Urowitz

Since Specialization

Citations

This map shows the geographic impact of Murray B. Urowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray B. Urowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray B. Urowitz more than expected).

Fields of papers citing papers by Murray B. Urowitz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray B. Urowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray B. Urowitz. The network helps show where Murray B. Urowitz may publish in the future.

Co-authorship network of co-authors of Murray B. Urowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Murray B. Urowitz. A scholar is included among the top collaborators of Murray B. Urowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray B. Urowitz. Murray B. Urowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Askanase, Anca, Richard Furie, Maria Dall’Era, et al.. (2024). Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus Science & Medicine. 11(1). e001124–e001124. 4 indexed citations

Gladman, Dafna D., et al.. (2024). Circulating neutrophil extracellular trap remnants as a biomarker to predict outcomes in lupus nephritis. Lupus Science & Medicine. 11(1). e001038–e001038. 12 indexed citations

Gold, Nicholas D., Jingjing Cao, Dafna D. Gladman, et al.. (2023). Genetics of longitudinal kidney function in children and adults with systemic lupus erythematosus. Lara D. Veeken. 62(11). 3749–3756. 1 indexed citations

Furie, Richard, Maria Dall’Era, Andrew S. Bomback, et al.. (2023). AB0531 APPLYING THE WORKING DEFINITION OF THE DISEASE MODIFICATION CRITERIA TO LUPUS NEPHRITIS TREATMENTS FROM THE PUBLISHED LITERATURE. Annals of the Rheumatic Diseases. 82. 1463–1464. 1 indexed citations

Clowse, Megan E. B., Amanda M. Eudy, Stephen J. Balevic, et al.. (2022). Hydroxychloroquine in the pregnancies of women with lupus: a meta-analysis of individual participant data. Lupus Science & Medicine. 9(1). e000651–e000651. 39 indexed citations

Vollenhoven, Ronald van, Anca Askanase, Andrew S. Bomback, et al.. (2022). Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus Science & Medicine. 9(1). e000634–e000634. 31 indexed citations

Furie, Richard, Ian N Bruce, Thomas Dörner, et al.. (2021). Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. Lara D. Veeken. 60(11). 5397–5407. 79 indexed citations

Almaghlouth, Ibrahim, Sindhu R. Johnson, Eleanor Pullenayegum, Dafna D. Gladman, & Murray B. Urowitz. (2021). Immunoglobulin levels in systemic lupus erythematosus: A narrative review. Lupus. 30(6). 867–875. 9 indexed citations

Tselios, Konstantinos, Dafna D. Gladman, Jiandong Su, & Murray B. Urowitz. (2020). Advanced Chronic Kidney Disease in Lupus Nephritis: Is Dialysis Inevitable?. The Journal of Rheumatology. 47(9). 1366–1373. 11 indexed citations

10.

Jorge, April, Ronald B. Melles, Yuqing Zhang, et al.. (2018). Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines. Arthritis Research & Therapy. 20(1). 133–133. 32 indexed citations

11.

Wang, Michelle, Dafna D. Gladman, Dominique Ibañez, & Murray B. Urowitz. (2012). Long‐term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Arthritis Care & Research. 64(6). 833–837. 8 indexed citations

12.

Touma, Zahi, et al.. (2012). Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Lara D. Veeken. 51(10). 1814–1819. 36 indexed citations

13.

Touma, Zahi, et al.. (2011). Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50 Enhances the Ability of SLE Responder Index to Identify Responders in Clinical Trials. The Journal of Rheumatology. 38(11). 2395–2399. 36 indexed citations

14.

Touma, Zahi, Dafna D. Gladman, Murray B. Urowitz, et al.. (2010). Mycophenolate Mofetil for Induction Treatment of Lupus Nephritis: A Systematic Review and Metaanalysis. The Journal of Rheumatology. 38(1). 69–78. 83 indexed citations

15.

Urowitz, Murray B., et al.. (2005). Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study. Annals of the Rheumatic Diseases. 65(1). 115–117. 21 indexed citations

16.

McLaughlin, John, et al.. (1994). Kidney biopsy in systemic lupus erythematosus. Arthritis & Rheumatism. 37(4). 559–567. 58 indexed citations

17.

Gladman, D., C. H. Goldsmith, Murray B. Urowitz, et al.. (1992). Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.. PubMed. 19(4). 608–11. 103 indexed citations

18.

Miller, Marian H., Murray B. Urowitz, & Dafna D. Gladman. (1983). The significance of thrombocytopenia in systemic lupus erythematosus. Arthritis & Rheumatism. 26(10). 1181–1186. 41 indexed citations

19.

Hastings, David E., et al.. (1977). The fixed lupus hand deformity and its surgical correction.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 4(2). 170–5. 13 indexed citations

20.

Hunter, Thomas, Murray B. Urowitz, Duncan A. Gordon, H A Smythe, & M. A. Ogryzlo. (1975). Azathioprine in rheumatoid arthritis. Arthritis & Rheumatism. 18(1). 15–20. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact